GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Market Cap

Guanhao Biotech Co (SZSE:300238) Market Cap : ¥2,709.9 Mil (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Guanhao Biotech Co's share price for the quarter that ended in Mar. 2024 was ¥10.74. Guanhao Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 265.2 Mil. Therefore, Guanhao Biotech Co's market cap for the quarter that ended in Mar. 2024 was ¥2,847.8 Mil.

Guanhao Biotech Co's quarterly market cap declined from Sep. 2023 (¥3,664.5 Mil) to Dec. 2023 (¥3,595.5 Mil) and declined from Dec. 2023 (¥3,595.5 Mil) to Mar. 2024 (¥2,847.8 Mil).

Guanhao Biotech Co's annual market cap declined from Dec. 2021 (¥4,913.3 Mil) to Dec. 2022 (¥2,725.8 Mil) but then increased from Dec. 2022 (¥2,725.8 Mil) to Dec. 2023 (¥3,595.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guanhao Biotech Co's Enterprise Value for Today is ¥2,719.3 Mil.


Guanhao Biotech Co Market Cap Historical Data

The historical data trend for Guanhao Biotech Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Market Cap Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,067.13 6,666.02 4,913.34 2,725.80 3,595.52

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,290.59 4,091.36 3,664.46 3,595.52 2,847.78

Competitive Comparison of Guanhao Biotech Co's Market Cap

For the Biotechnology subindustry, Guanhao Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Market Cap falls into.



Guanhao Biotech Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Guanhao Biotech Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥13.56*265.156
=¥3,595.5

Guanhao Biotech Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥10.74*265.156
=¥2,847.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guanhao Biotech Co  (SZSE:300238) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Guanhao Biotech Co Market Cap Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines